Novel Oral Anticoagulants: A Focused Review for Stroke Physicians Journal Articles

abstract

• Novel oral anticoagulants provide an effective and convenient alternative to warfarin for stroke prevention in patients with atrial fibrillation. However, novel anticoagulants also present new challenges for stroke physicians, such as measurement of anticoagulant effect in emergency situations, use of thrombolysis in acute ischemic stroke, optimal timing of introduction of novel anticoagulants following acute ischemic stroke, and management of intracerebral hemorrhage. In this review, we propose pragmatic approaches to dealing with challenging management issues that will face stroke physicians who care for patients with acute stroke in the novel oral anticoagulant era.

authors

• McGrath, Emer R
• Eikelboom, John
• Kapral, Moira K
• O'Donnell, Martin

status

• published 

publication date

• January 2014

has subject area

• 1103 Clinical Sciences (FoR)
• 1109 Neurosciences (FoR)
• Administration, Oral (MeSH)
• Anticoagulants (MeSH)
• Benzimidazoles (MeSH)
• Child (MeSH)
• Dabigatran (MeSH)
• Humans (MeSH)
• Morpholines (MeSH)
• Neurology & Neurosurgery (Science Metrix)
• Pyrazoles (MeSH)
• Pyridines (MeSH)
• Pyridones (MeSH)
• Rivaroxaban (MeSH)
• Stroke (MeSH)
• Thiophenes (MeSH)

published in

• International Journal of Stroke  Journal

keywords

• Administration, Oral
• Anticoagulants
• Benzimidazoles
• Child
• Dabigatran
• Humans
• Morpholines
• Pyrazoles
• Pyridines
• Pyridones
• Rivaroxaban
• Stroke
• Thiophenes
• atrial fibrillation
• ischemic stroke
• novel anticoagulants

Digital Object Identifier (DOI)

• 10.1111/ijs.12158

PubMed ID

• 24148753

start page

• 71

end page

• 78

volume

• 9

issue

• 1